Abstract
Although cisplatin is one of the chemotherapeutics most frequently used in oral squamous cell carcinoma (OSCC) treatment, it exerts multiple side effects and poor chemosensitivity. Nitrate reportedly demonstrates several beneficial biological functions, and synthesized nitrates enhance the therapeutic efficacy of chemotherapy. However, the role of inorganic nitrate in cisplatin chemotherapy remains unclear. We therefore investigated the effect of inorganic nitrate exerted on cisplatin sensitivity in OSCC. We found that nitrate did not affect OSCC cell growth and apoptosis in OSCC cells and OSCC xenograft tumor animal studies. Cisplatin induced REDD1 expression and AKT activation in OSCC. However, nitrate could increase cisplatin chemosensitivity, reduce its REDD1 expression, and attenuate AKT signaling activation in OSCC cells. Dysregulation of high levels of REDD1, which could enhance AKT activation, was positively associated with poor prognosis in OSCC patients. Thus, reduced REDD1 expression and retarded AKT activation induced by inorganic nitrate might be a new potential approach to the sensitization of oral cancer to cisplatin treatment in the future.
Similar content being viewed by others
References
Angelidou, I., Chrysanthopoulou, A., Mitsios, A., Arelaki, S., Arampatzioglou, A., Kambas, K., Ritis, D., Tsironidou, V., Moschos, I., Dalla, V., et al. (2018). REDD1/autophagy pathway is associated with neutrophil-driven IL-1β inflammatory response in active ulcerative colitis. J Immunol 200, 3950–3961.
Azizzadeh, B., Yip, H.T., Blackwell, K.E., Horvath, S., Calcaterra, T.C., Buga, G.M., Ignarro, L.J., and Wang, M.B. (2001). Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 111, 1896–1900.
Barra, F., Evangelisti, G., Ferro Desideri, L., Di Domenico, S., Ferraioli, D., Vellone, V.G., De Cian, F., and Ferrero, S. (2019). Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer. Expert Opin Investig Drugs 28, 131–142.
Brix, B., Mesters, J.R., Pellerin, L., and Jöhren, O. (2012). Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes via HIF-1α-mediated target gene activation. J Neurosci 32, 9727–9735.
Brugarolas, J., Lei, K., Hurley, R.L., Manning, B.D., Reiling, J.H., Hafen, E., Witters, L.A., Ellisen, L.W., and Kaelin, W.G. (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18, 2893–2904.
Bryan, N.S., Alexander, D.D., Coughlin, J.R., Milkowski, A.L., and Boffetta, P. (2012). Ingested nitrate and nitrite and stomach cancer risk: an updated review. Food Chem Toxicol 50, 3646–3665.
Bussink, J., van der Kogel, A.J., and Kaanders, J.H. (2008). Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 9, 288–296.
Calmels, S., Hainaut, P., and Ohshima, H. (1997). Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 57, 3365–3369.
Cam, M., Bid, H.K., Xiao, L., Zambetti, G.P., Houghton, P.J., and Cam, H. (2014). p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage. J Biol Chem 289, 4083–4094.
Chang, B., Liu, G., Yang, G., Mercado-Uribe, I., Huang, M., and Liu, J. (2009). REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells. Cell Cycle 8, 780–786.
Chang, B., Meng, J., Zhu, H., Du, X., Sun, L., Wang, L., Li, S., and Yang, G. (2018). Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma. Diagn Pathol 13, 87.
Chang, C.H., Lee, C.Y., Lu, C.C., Tsai, F.J., Hsu, Y.M., Tsao, J.W., Juan, Y. N., Chiu, H.Y., Yang, J.S., and Wang, C.C. (2017). Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling. Int J Oncol 50, 873–882.
Chang, S., Hu, L., Xu, Y., Li, X., Ma, L., Feng, X., Wang, J., Zhang, C., and Wang, S. (2019). Inorganic nitrate alleviates total body irradiation-induced systemic damage by decreasing reactive oxygen species levels. Int J Radiat Oncol Biol Phys 103, 945–957.
Chi, A.C., Day, T.A., and Neville, B.W. (2015). Oral cavity and oropharyngeal squamous cell carcinoma—an update. CA Cancer J Clin 65, 401–421.
Clavo, B., Robaina, F., Fiuza, D., Ruiz, A., Lloret, M., Rey-Baltar, D., Llontop, P., Riveros, A., Rivero, J., Castañeda, F., et al. (2017). Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification. Clin Transl Oncol 19, 419–424.
Corradetti, M.N., Inoki, K., and Guan, K.L. (2005). The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J Biol Chem 280, 9769–9772.
Dennis, M.D., McGhee, N.K., Jefferson, L.S., and Kimball, S.R. (2013). Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1). Cell Signal 25, 2709–2716.
Ellisen, L.W., Ramsayer, K.D., Johannessen, C.M., Yang, A., Beppu, H., Minda, K., Oliner, J.D., McKeon, F., and Haber, D.A. (2002). REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10, 995–1005.
Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., and Bray, F. (2018). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103, 356–387.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., and Bray, F. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–E386.
Franke, T.F., Hornik, C.P., Segev, L., Shostak, G.A., and Sugimoto, C. (2003). PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983–8998.
Frederiksen, L.J., Sullivan, R., Maxwell, L.R., Macdonald-Goodfellow, S. K., Adams, M.A., Bennett, B.M., Siemens, D.R., and Graham, C.H. (2007). Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res 13, 2199–2206.
Ghani, W.M.N., Ramanathan, A., Prime, S.S., Yang, Y.H., Razak, I.A., Abdul Rahman, Z.A., Abraham, M.T., Mustafa, W.M.W., Tay, K.K., Kallarakkal, T.G., et al. (2019). Survival of oral cancer patients in different ethnicities. Cancer Invest 37, 275–287.
Gong, J., Zhou, S., and Yang, S. (2019). Vanillic acid suppresses HIF-1α expression via inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK pathways in human colon cancer HCT116 cells. Int J Mol Sci 20, 465.
Gong, W.J., Peng, J.B., Yin, J.Y., Li, X.P., Zheng, W., Xiao, L., Tan, L.M., Xiao, D., Chen, Y.X., Li, X., et al. (2017). Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer. Acta Pharmacol Sin 38, 581–590.
Guo, G.F., Wang, Y.X., Zhang, Y.J., Chen, X.X., Lu, J.B., Wang, H.H., Jiang, C., Qiu, H.Q., and Xia, L.P. (2019). Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. World J Gastroenterol 25, 1840–1853.
Hall, M.D., Okabe, M., Shen, D.W., Liang, X.J., and Gottesman, M.M. (2008). The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48, 495–535.
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., and Lo, E.H. (2016). Transfer of mitochondria from astrocytes to neurons after stroke. Nature 535, 551–555.
Hernández-Ramírez, R.U., Galván-Portillo, M.V., Ward, M.H., Agudo, A., González, C.A., Oñate-Ocaña, L.F., Herrera-Goepfert, R., Palma-Coca, O., and López-Carrillo, L. (2009). Dietary intake of polyphenols, nitrate and nitrite and gastric cancer risk in Mexico City. Int J Cancer 125, 1424–1430.
Hu, L., Jin, L., Xia, D., Zhang, Q., Ma, L., Zheng, H., Xu, T., Chang, S., Li, X., Xun, Z., et al. (2020). Nitrate ameliorates dextran sodium sulfate-induced colitis by regulating the homeostasis of the intestinal microbiota. Free Radic Biol Med 152, 609–621.
Hu, M., Huang, P., Ma, Y., Ling, S., Li, Y., Chen, B., and Xu, Y. (2017). Effect of Redd1 loss on proliferation and metastasis of pancreatic cancer cells with KrasG12D-LOH by inhibiting glycolysis. J Clin Oncol 35, e15741.
Huang, Z., Zhang, Y., Li, H., Zhou, Y., Zhang, Q., Chen, R., Jin, T., Hu, K., Li, S., Wang, Y., et al. (2019). Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. Cell Death Dis 10, 936.
Huerta, S., Chilka, S., and Bonavida, B. (2008). Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol 33, 909–927.
Humans, I.W.G.o.t.E.o.C.R.t. (2010). IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr Eval Carcinog Risks Hum 94, v–vii, 1–412.
Igwe, E.I., Essler, S., Al-Furoukh, N., Dehne, N., and Brüne, B. (2009). Hypoxic transcription gene profiles under the modulation ofnitric oxide in nuclear run on-microarray and proteomics. BMC Genomics 10, 408.
Jakszyn, P., and Gonzalez, C.A. (2006). Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 12, 4296–4303.
Javadinia, S.A., Shahidsales, S., Fanipakdel, A., Mostafapour, A., Joudi-Mashhad, M., Ferns, G.A., and Avan, A. (2019). The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs: a novel marker for prognosis, and a possible target for immunotherapy. Curr Pharm Des 24, 4646–4651.
Jia, W., Chang, B., Sun, L., Zhu, H., Pang, L., Tao, L., Zou, H., Du, J., Dong, Y., Qi, Y., et al. (2014). REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer. Int J Clin Exp Pathol 7, 5940–5949.
Jin, H.O., Hong, S.E., Kim, J.H., Choi, H.N., Kim, K., An, S., Choe, T.B., Hwang, C.S., Lee, J.H., Kim, J.I., et al. (2013). Sustained overexpression of Redd1 leads to Akt activation involved in cell survival. Cancer Lett 336, 319–324.
Kalaycioglu, Z., and Erim, F.B. (2019). Nitrate and nitrites in foods: worldwide regional distribution in view of their risks and benefits. J Agric Food Chem 67, 7205–7222.
Khan, K.H., Yap, T.A., Yan, L., and Cunningham, D. (2013). Targeting the PI3K-AKT-mTOR signaling network in cancer. Chin J Cancer 32, 253–265.
Knuefermann, C., Lu, Y., Liu, B., Jin, W., Liang, K., Wu, L., Schmidt, M., Mills, G.B., Mendelsohn, J., and Fan, Z. (2003). HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 22, 3205–3212.
Kondapaka, S.B., Singh, S.S., Dasmahapatra, G.P., Sausville, E.A., and Roy, K.K. (2003). Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther 2, 1093–1103.
Krock, B.L., Skuli, N., and Simon, M.C. (2011). Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2, 1117–1133.
Lee, J.Y., Hirota, S.A., Glover, L.E., Armstrong, G.D., Beck, P.L., and MacDonald, J.A. (2013a). Effects of nitric oxide and reactive oxygen species on HIF-1α stabilization following Clostridium Difficile toxin exposure of the Caco-2 epithelial cell line. Cell Physiol Biochem 32, 417–430.
Lee, M., Bikram, M., Oh, S., Bull, D.A., and Kim, S.W. (2004). Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease. Pharm Res 21, 736–741.
Lee, S.Y., Kang, H.G., Yoo, S.S., Kang, Y.R., Choi, Y.Y., Lee, W.K., Choi, J.E., Jeon, H.S., Shin, K.M., Oh, I.J., et al. (2013b). Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy. Lung Cancer 82, 330–339.
Li, X.H., Ha, C.T., Fu, D., and Xiao, M. (2012). REDD1 protects osteoblast cells from gamma radiation-induced premature senescence. PLoS ONE 7, e36604.
Liu, P., Cheng, H., Roberts, T.M., and Zhao, J.J. (2009). Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8, 627–644.
Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the \({2^{ - \Delta \Delta {C_{\rm{T}}}}}\) method. Methods 25, 402–408.
Lundberg, J.O., Gladwin, M.T., Ahluwalia, A., Benjamin, N., Bryan, N.S., Butler, A., Cabrales, P., Fago, A., Feelisch, M., Ford, P.C., et al. (2009). Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 5, 865–869.
Lundberg, J.O., and Govoni, M. (2004). Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 37, 395–400.
Ma, L., Hu, L., Feng, X., and Wang, S. (2018). Nitrate and nitrite in health and disease. Aging Dis 9, 938–945.
Masthan, K.M.K., Babu, N.A., Dash, K.C., and Elumalai, M. (2012). Advanced diagnostic aids in oral cancer. Asian Pac J Cancer Prevention 13, 3573–3576.
McGhee, N.K., Jefferson, L.S., and Kimball, S.R. (2009). Elevated corticosterone associated with food deprivation upregulates expression in rat skeletal muscle of the mTORC1 repressor, REDD1. J Nutr 139, 828–834.
Mirza, A.M., Gysin, S., Malek, N., Nakayama, K., Roberts, J.M., and McMahon, M. (2004). Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol 24, 10868–10881.
Ning, S., Bednarski, M., Oronsky, B., Scicinski, J., and Knox, S.J. (2014). Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy. Biochem Biophys Res Commun 447, 537–542.
Perrotta, C., Bizzozero, L., Falcone, S., Rovere-Querini, P., Prinetti, A., Schuchman, E.H., Sonnino, S., Manfredi, A.A., and Clementi, E. (2007). Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res 67, 7559–7564.
Qiao, S., Dennis, M., Song, X., Vadysirisack, D.D., Salunke, D., Nash, Z., Yang, Z., Liesa, M., Yoshioka, J., Matsuzawa, S.I., et al. (2015). A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity. Nat Commun 6, 7014.
Riaño, A., Ortiz-Masià, D., Velázquez, M., Calatayud, S., Esplugues, J.V., and Barrachina, M.D. (2011). Nitric oxide induces HIF-1α stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. J Gastroenterol 46, 565–576.
Rishi, L., Dhiman, R., Raje, M., and Majumdar, S. (2007). Nitric oxide induces apoptosis in cutaneous T cell lymphoma (HuT-78) by downregulating constitutive NF-kB. Biochim Biophys Acta 1770, 1230–1239.
Scagliotti, G.V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008). Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26, 3543–3551.
Schneider, C.A., Rasband, W.S., and Eliceiri, K.W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671–675.
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., et al. (2002). Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22, 2283–2293.
Siegel, R.L., Miller, K.D., and Jemal, A. (2018). Cancer statistics, 2018. CA Cancer J Clin 68, 7–30.
Sofer, A., Lei, K., Johannessen, C.M., and Ellisen, L.W. (2005). Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25, 5834–5845.
Song, P., Wu, L., and Guan, W. (2015). Dietary nitrates, nitrites, and nitrosamines intake and the risk of gastric cancer: a meta-analysis. Nutrients 7, 9872–9895.
Stanimirovic, J., Obradovic, M., Jovanovic, A., Sudar-Milovanovic, E., Zafirovic, S., Pitt, S.J., Stewart, A.J., and Isenovic, E.R. (2016). A high fat diet induces sex-specific differences in hepatic lipid metabolism and nitrite/nitrate in rats. Nitric Oxide 54, 51–59.
Tanzawa, H., Uzawa, K., Kasamatsu, A., Endo-Sakamoto, Y., Saito, K., Ogawara, K., and Shiiba, M. (2015). Targeting gene therapies enhance sensitivity to chemo- and radiotherapy of human oral squamous cell carcinoma. Oral Sci Int 12, 43–52.
Thavarool, S.B., Muttath, G., Nayanar, S., Duraisamy, K., Bhat, P., Shringarpure, K., Nayak, P., Tripathy, J.P., Thaddeus, A., Philip, S., et al. (2019). Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India. World J Surg Onc 17, 15.
Turpaev, K., Glatigny, A., Bignon, J., Delacroix, H., and Drapier, J.C. (2010). Variation in gene expression profiles ofhuman monocytic U937 cells exposed to various fluxes of nitric oxide. Free Radic Biol Med 48, 298–305.
van Dijk, B.A.C., Brands, M.T., Geurts, S.M.E., Merkx, M.A.W., and Roodenburg, J.L.N. (2016). Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer 139, 574–583.
Vermorken, J.B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.R., Cupissol, D., et al. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359, 1116–1127.
Wang, H., Kubica, N., Ellisen, L.W., Jefferson, L.S., and Kimball, S.R. (2006). Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 281, 39128–39134.
Wang, H., Hu, L., Li, L., Wu, X., Fan, Z., Zhang, C., Wang, J., Jia, J., and Wang, S. (2018). Inorganic nitrate alleviates the senescence-related decline in liver function. Sci China Life Sci 61, 24–34.
Wang, N., Feng, Y., Wang, Q., Liu, S., Xiang, L., Sun, M., Zhang, X., Liu, G., Qu, X., and Wei, F. (2014a). Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells. PLoS ONE 9, e89991.
Wang, N., Wang, Q.J., Feng, Y.Y., Shang, W., and Cai, M. (2014b). Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue. Clin Oral Invest 18, 997–1004.
Wang, N., Wang, Q., Chi, J., Xiang, F., Lin, M., Wang, W., Wei, F., and Feng, Y. (2019). Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma. Cancer Sci 110, 519–529.
Whitney, M.L., Jefferson, L.S., and Kimball, S.R. (2009). ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. Biochem Biophys Res Commun 379, 451–455.
Wu, H., Huang, S., and Zhang, D. (2015). Autophagic responses to hypoxia and anticancer therapy in head and neck cancer. Pathol Res Pract 211, 101–108.
Wu, Y.Y., Wu, H.C., Wu, J.E., Huang, K.Y., Yang, S.C., Chen, S.X., Tsao, C.J., Hsu, K.F., Chen, Y.L., and Hong, T.M. (2019). The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens. J Exp Clin Cancer Res 38, 282.
Xia, D., Qu, X., Tran, S.D., Schmidt, L.L., Qin, L., Zhang, C., Cui, X., Deng, D., and Wang, S. (2015). Histological characteristics following a long-term nitrate-rich diet in miniature pigs with parotid atrophy. Int J Clin Exp Pathol 8, 6225–6234.
Xu, Y., Pang, B., Hu, L., Feng, X., Hu, L., Wang, J., Zhang, C., and Wang, S. (2018). Dietary nitrate protects submandibular gland from hyposalivation in ovariectomized rats via suppressing cell apoptosis. Biochem Biophys Res Commun 497, 272–278.
Zeng, Q., Liu, J., Cao, P., Li, J., Liu, X., Fan, X., Liu, L., Cheng, Y., Xiong, W., Li, J., et al. (2018). Inhibition of REDD1 sensitizes bladder urothelial carcinoma to paclitaxel by inhibiting autophagy. Clin Cancer Res 24, 445–459.
Zhong, L., Zhang, C., Ren, G., Guo, W., William Jr, W.N., Sun, J., Zhu, H., Tu, W., Li, J., Cai, Y., et al. (2013). Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31, 744–751.
Acknowledgements
This work was supported by the CAMS Innovation Fund for Medical Sciences (2019-I2M-5-031), Beijing Hospitals Authority of Hospitals’ Mission Plan (SML20151401, Capital Medical University), Beijing Municipality Government grants (Beijing Scholar Program—PXM2020_014226_000005, PXM2019_014226_000039, PXM2019_014226_000011, PXM2018_014226_000021, PXM2017_014226_000023, PXM2018_193312_000006_0028S643_FCG, PXM2016_014226_000034), and the National Natural Science Foundation of China (91649124)
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Compliance and ethics The author(s) declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Feng, Y., Cao, X., Zhao, B. et al. Nitrate increases cisplatin chemosensitivity of oral squamous cell carcinoma via REDD1/AKT signaling pathway. Sci. China Life Sci. 64, 1814–1828 (2021). https://doi.org/10.1007/s11427-020-1978-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-020-1978-4